Leaflet BRIVARACETAM DESITIN 75mg film-coated tablets
Indicated for: epilepsy
Route of administration: oral
Substance: brivaracetam (antiepileptic)
ATC: N03AX23 (Nervous system | Antiepileptics | Other antiepileptics)
This medicine may affect your ability to drive or use machines.
Dose adjustment may be needed in liver disease.
Dose adjustment may be needed in kidney disease.
This medicine may cause dizziness or vertigo.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Seek medical help if suicidal thoughts or major behavior changes occur.
This medicine may cause drowsiness or reduced alertness.
Brivaracetam is a medication used for the treatment of epilepsy, specifically focal seizures with or without secondary generalization, in patients aged 4 years and older. It is an antiepileptic drug that works by binding to the synaptic vesicle protein SV2A, reducing neuronal excitability.
The medication is administered orally or intravenously, as directed by a doctor. The dosage is adjusted based on the patient's age, weight, and response to treatment.
Common side effects include drowsiness, dizziness, fatigue, and irritability. In rare cases, more severe adverse effects such as depression or suicidal thoughts may occur, requiring close monitoring of patients.
Brivaracetam is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.
General data about BRIVARACETAM DESITIN 75mg
- Substance: brivaracetam
- Date of last drug list: 01-02-2026
- Commercial code: W71624001
- Concentration: 75mg
- Pharmaceutical form: film-coated tablets
- Quantity: 14
- Product type: generic
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for brivaracetam
Concentrations available for brivaracetam
- 100mg
- 10mg
- 10mg/ml
- 25mg
- 50mg
- 75mg